Reliability of whole mount radical prostatectomy histopathology as the ground truth for artificial intelligence assisted prostate imaging.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 20 04 2023
accepted: 26 06 2023
revised: 05 06 2023
medline: 10 8 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

The development of artificial intelligence-based imaging techniques for prostate cancer (PCa) detection and diagnosis requires a reliable ground truth, which is generally based on histopathology from radical prostatectomy specimens. This study proposes a comprehensive protocol for the annotation of prostatectomy pathology slides. To evaluate the reliability of the protocol, interobserver variability was assessed between five pathologists, who annotated ten radical prostatectomy specimens consisting of 74 whole mount pathology slides. Interobserver variability was assessed for both the localization and grading of PCa. The results indicate excellent overall agreement on the localization of PCa (Gleason pattern ≥ 3) and clinically significant PCa (Gleason pattern ≥ 4), with Dice similarity coefficients (DSC) of 0.91 and 0.88, respectively. On a per-slide level, agreement for primary and secondary Gleason pattern was almost perfect and substantial, with Fleiss Kappa of .819 (95% CI .659-.980) and .726 (95% CI .573-.878), respectively. Agreement on International Society of Urological Pathology Grade Group was evaluated for the index lesions and showed agreement in 70% of cases, with a mean DSC of 0.92 for all index lesions. These findings show that a standardized protocol for prostatectomy pathology annotation provides reliable data on PCa localization and grading, with relatively high levels of interobserver agreement. More complicated tissue characterization, such as the presence of cribriform growth and intraductal carcinoma, remains a source of interobserver variability and should be treated with care when used in ground truth datasets.

Identifiants

pubmed: 37407736
doi: 10.1007/s00428-023-03589-4
pii: 10.1007/s00428-023-03589-4
pmc: PMC10412486
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

197-206

Subventions

Organisme : European Union
ID : 101057919

Informations de copyright

© 2023. The Author(s).

Références

Acad Radiol. 2004 Feb;11(2):178-89
pubmed: 14974593
Am J Surg Pathol. 2020 Aug;44(8):e87-e99
pubmed: 32459716
Mod Pathol. 2019 Jan;32(1):139-146
pubmed: 30349027
Lancet Digit Health. 2020 Aug;2(8):e407-e416
pubmed: 33328045
Scand J Urol. 2016 Dec;50(6):420-424
pubmed: 27416104
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
Urology. 2002 Aug;60(2):264-9
pubmed: 12137824
Mod Pathol. 2015 Mar;28(3):457-64
pubmed: 25189638
Urology. 2011 May;77(5):1155-60
pubmed: 21146858
Eur Urol Focus. 2022 Sep;8(5):1187-1191
pubmed: 34922897
Histopathology. 2006 May;48(6):644-54
pubmed: 16681679
Radiology. 2020 Apr;295(1):4-15
pubmed: 32068507
J Magn Reson Imaging. 2021 Aug;54(2):462-471
pubmed: 33719168
Eur Radiol. 2020 Feb;30(2):806-815
pubmed: 31602512
J Magn Reson Imaging. 2021 Jun;53(6):1632-1645
pubmed: 32410356
J Urol. 2011 Nov;186(5):1818-24
pubmed: 21944089
Am J Surg Pathol. 2021 Aug 1;45(8):1118-1126
pubmed: 33999555
Eur Urol. 2016 Nov;70(5):846-853
pubmed: 26810346
Virchows Arch. 2021 Feb;478(2):249-256
pubmed: 32815034
Eur Urol Open Sci. 2023 Jan 26;49:32-43
pubmed: 36874606
Can Urol Assoc J. 2021 Jan;15(1):E11-E16
pubmed: 32701437
Histopathology. 2016 Sep;69(3):441-9
pubmed: 27028587
Radiology. 2018 Mar;286(3):800-809
pubmed: 29309734
BJU Int. 2020 Oct;126(4):481-493
pubmed: 32315112
Eur Urol Focus. 2022 Mar;8(2):409-417
pubmed: 33773964

Auteurs

Auke Jager (A)

Amsterdam UMC, University of Amsterdam, Department of Urology, Meibergdreef 9, Amsterdam, The Netherlands. a.jager1@amsterdamumc.nl.

Arnoud W Postema (AW)

Amsterdam UMC, University of Amsterdam, Department of Urology, Meibergdreef 9, Amsterdam, The Netherlands.
Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Hans van der Linden (H)

Pathology DNA, Jeroen Bosch Hospital, Henri Dunantstraat 1, 5223, GZ, 's-Hertogenbosch, The Netherlands.

Peet T G A Nooijen (PTGA)

Pathology DNA, Jeroen Bosch Hospital, Henri Dunantstraat 1, 5223, GZ, 's-Hertogenbosch, The Netherlands.

Elise Bekers (E)

Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Charlotte F Kweldam (CF)

Department of pathology, Maasstad Ziekenhuis, Rotterdam, The Netherlands.

Gautier Daures (G)

Angiogenesis Analytics, JADS Venture Campus, 's-Hertogenbosch, AA, The Netherlands.

Wim Zwart (W)

Angiogenesis Analytics, JADS Venture Campus, 's-Hertogenbosch, AA, The Netherlands.

M Mischi (M)

Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.

Harrie P Beerlage (HP)

Amsterdam UMC, University of Amsterdam, Department of Urology, Meibergdreef 9, Amsterdam, The Netherlands.

Jorg R Oddens (JR)

Amsterdam UMC, University of Amsterdam, Department of Urology, Meibergdreef 9, Amsterdam, The Netherlands.
Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH